LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2018

Mar 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2018-02-28

Reporting Person: Santini Alexander A (EVP and CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-28	Common Stock	M	2353	—	Acquired	3612	Direct
2018-02-28	Common Stock	M	2592	—	Acquired	6204	Direct
2018-02-28	Common Stock	F	1652	$8.53	Disposed	4552	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-28	Restricted Stock Units	$	M	2353	Disposed		Common Stock (2353)	Direct
2018-02-28	Restricted Stock Units	$	M	2592	Disposed		Common Stock (2592)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F4: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.